Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 3
2009 2
2010 2
2013 2
2015 3
2016 3
2017 2
2018 1
2020 1
2021 3
2022 3
2023 4
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Free article. Clinical Trial.
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R; NORD-STAR study group. Hetland ML, et al. BMJ. 2020 Dec 2;371:m4328. doi: 10.1136/bmj.m4328. BMJ. 2020. PMID: 33268527 Free PMC article. Clinical Trial.
Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients.
Bento da Silva A, Ramiro S, van Lunteren M, Marques ML, van de Sande M, Fongen C, Exarchou S, Ramonda R, van der Heijde D, van Gaalen FA. Bento da Silva A, et al. Among authors: exarchou s. RMD Open. 2024 Oct 26;10(4):e004713. doi: 10.1136/rmdopen-2024-004713. RMD Open. 2024. PMID: 39461873 Free PMC article.
Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort.
Bosch P, Sepriano A, Marques ML, van der Heijde D, Landewé R, van Lunteren M, de Bruin L, de Hooge M, Bastiaenen C, Exarchou S, Ramonda R, Fagerli KM, van Gaalen FA, Ramiro S. Bosch P, et al. Among authors: exarchou s. RMD Open. 2024 Sep 30;10(3):e004584. doi: 10.1136/rmdopen-2024-004584. RMD Open. 2024. PMID: 39349053 Free PMC article.
The lipid paradox is also present in early axial spondyloarthritis: results from the Swedish part of the SPondyloArthritis Caught Early (SPACE) cohort.
Jacobsson L, Forsblad d'Elia H, Husmark T, Lopis Soler J, Nilsson N, Lindström U, Klingberg E, Linnerud Keshvarz M, Rizk M, Larsson P, van Gaalen FA, Turesson C, Exarchou S. Jacobsson L, et al. Among authors: exarchou s. Scand J Rheumatol. 2025 Mar;54(2):106-111. doi: 10.1080/03009742.2024.2388404. Epub 2024 Oct 11. Scand J Rheumatol. 2025. PMID: 39392287 Free article.
Measuring quality of life of patients with axial spondyloarthritis for economic evaluation.
Hernandez Alava M, Wailoo A, Chrysanthou G, Barcelos F, van Gaalen FA, Santos H, Fagerli KM, Gago L, Margarida Cunha M, van de Sande M, Couto MC, Bernardes M, Ramonda R, Exarchou S, Carvalho PD, van der Heijde D, Machado PM. Hernandez Alava M, et al. Among authors: exarchou s. RMD Open. 2022 Feb;8(1):e001955. doi: 10.1136/rmdopen-2021-001955. RMD Open. 2022. PMID: 35177554 Free PMC article.
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden.
Exarchou S, Di Giuseppe D, Klingberg E, Sigurdardottir V, Wedrén S, Lindström U, Turesson C, Jacobsson LTH, Askling J, Wallman JK. Exarchou S, et al. J Rheumatol. 2025 Jan 1;52(1):38-46. doi: 10.3899/jrheum.2024-0376. J Rheumatol. 2025. PMID: 39278652 Free article.
35 results